Quercis Pharma AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.quercis.com
The Effect of Isoquercetin on Thromboembolic Events in Patients with Metastatic Pancreatic Cancer
Phase 3
Not yet recruiting
- Conditions
- Venous ThromboembolismMetastatic Pancreatic Cancer
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Quercis Pharma AG
- Target Recruit Count
- 340
- Registration Number
- NCT06861088
© Copyright 2025. All Rights Reserved by MedPath